Clinical Trial

Prospective Observational Basket Study of Stereotactic Body Radiation Therapy for OligoMetastatic Patients From Rare Tumors

Study acronym: PROMPT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 25, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This prospective observational study aims to investigate the effectiveness and safety of SBRT in the management of oligometastases from rare tumors. In addition, the study aims to identify potential differences in treatment efficacy and toxicity between different types of cancer and to provide valuable information on the use of SBRT in these contexts, potentially leading to better treatment options and outcomes for these patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-05.
Status change: Not Yet Recruiting → Recruiting 2025-04-22
Trial Details
NCT Number NCT05903261
Lead Sponsor Istituto Clinico Humanitas
Conditions Oligometastatic Disease
Enrollment 200 participants
Start Date 2023-06-09
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-04-25